223 related articles for article (PubMed ID: 38004817)
1. Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey.
Parigi TL; Vieujean S; Paridaens K; Dalgaard K; Peyrin-Biroulet L; Danese S
Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004817
[TBL] [Abstract][Full Text] [Related]
2. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
3. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
[TBL] [Abstract][Full Text] [Related]
4. An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases.
Waller KMJ; Leong RW; Paramsothy S
J Gastroenterol Hepatol; 2022 Feb; 37(2):246-255. PubMed ID: 34735024
[TBL] [Abstract][Full Text] [Related]
5. Chinese physicians' perceptions of fecal microbiota transplantation.
Ren RR; Sun G; Yang YS; Peng LH; Wang SF; Shi XH; Zhao JQ; Ban YL; Pan F; Wang XH; Lu W; Ren JL; Song Y; Wang JB; Lu QM; Bai WY; Wu XP; Wang ZK; Zhang XM; Chen Y
World J Gastroenterol; 2016 May; 22(19):4757-65. PubMed ID: 27217707
[TBL] [Abstract][Full Text] [Related]
6. The Gut Microbiome as a Target for IBD Treatment: Are We There Yet?
Knox NC; Forbes JD; Van Domselaar G; Bernstein CN
Curr Treat Options Gastroenterol; 2019 Mar; 17(1):115-126. PubMed ID: 30661163
[TBL] [Abstract][Full Text] [Related]
7. Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease.
Zhang X; Ishikawa D; Ohkusa T; Fukuda S; Nagahara A
Front Med (Lausanne); 2022; 9():1068567. PubMed ID: 36530877
[TBL] [Abstract][Full Text] [Related]
8. Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Paramsothy S; Paramsothy R; Rubin DT; Kamm MA; Kaakoush NO; Mitchell HM; Castaño-Rodríguez N
J Crohns Colitis; 2017 Oct; 11(10):1180-1199. PubMed ID: 28486648
[TBL] [Abstract][Full Text] [Related]
9. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
Naseer M; Poola S; Ali S; Samiullah S; Tahan V
Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
[TBL] [Abstract][Full Text] [Related]
10. Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
Lopez J; Grinspan A
Gastroenterol Hepatol (N Y); 2016 Jun; 12(6):374-9. PubMed ID: 27493597
[TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplant - a new frontier in inflammatory bowel disease.
Sunkara T; Rawla P; Ofosu A; Gaduputi V
J Inflamm Res; 2018; 11():321-328. PubMed ID: 30214266
[TBL] [Abstract][Full Text] [Related]
12. Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation.
Jeon SR; Chai J; Kim C; Lee CH
Curr Infect Dis Rep; 2018 May; 20(8):21. PubMed ID: 29804272
[TBL] [Abstract][Full Text] [Related]
13. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease.
Wang AY; Popov J; Pai N
World J Gastroenterol; 2016 Dec; 22(47):10304-10315. PubMed ID: 28058011
[TBL] [Abstract][Full Text] [Related]
15. Current and future microbiome-based therapies in inflammatory bowel disease.
Montrose JA; Kurada S; Fischer M
Curr Opin Gastroenterol; 2024 Jul; 40(4):258-267. PubMed ID: 38841848
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review.
Kasapoglu M; Yadavalli R; Nawaz S; Althwanay A; AlEdani EM; Kaur H; Butt S
Cureus; 2024 May; 16(5):e60786. PubMed ID: 38779440
[TBL] [Abstract][Full Text] [Related]
17. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation.
He R; Li P; Wang J; Cui B; Zhang F; Zhao F
Gut Microbes; 2022; 14(1):2100197. PubMed ID: 35854629
[TBL] [Abstract][Full Text] [Related]
18. Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
Kump P; Högenauer C
Dig Dis; 2016; 34 Suppl 1():74-81. PubMed ID: 27548724
[TBL] [Abstract][Full Text] [Related]
19. Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases.
Cammarota G; Pecere S; Ianiro G; Masucci L; Currò D
Dig Dis; 2016; 34(3):279-85. PubMed ID: 27027524
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
Eindor-Abarbanel A; Healey GR; Jacobson K
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
